Arcturus Therapeutics Holdings, Inc. (ARCT)
16.45
+0.22
(+1.39%)
USD |
NASDAQ |
Sep 02, 12:57
Arcturus Therapeutics Holdings Cash from Investing (Quarterly) : 0.0193M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0193M |
| March 31, 2026 | 0.034M |
| December 31, 2025 | 0.0886M |
| September 30, 2025 | -0.1949M |
| June 30, 2025 | -0.0006M |
| March 31, 2025 | -0.137M |
| December 31, 2024 | -0.0019M |
| September 30, 2024 | -0.0821M |
| June 30, 2024 | -0.3233M |
| March 31, 2024 | -0.24M |
| December 31, 2023 | -0.8371M |
| September 30, 2023 | -0.9339M |
| June 30, 2023 | -0.3372M |
| March 31, 2023 | -0.691M |
| December 31, 2022 | -3.639M |
| September 30, 2022 | -2.106M |
| June 30, 2022 | 0.4171M |
| March 31, 2022 | -2.111M |
| December 31, 2021 | -1.185M |
| September 30, 2021 | -1.780M |
| June 30, 2021 | -0.4049M |
| March 31, 2021 | -0.118M |
| December 31, 2020 | -0.7352M |
| September 30, 2020 | -0.4527M |
| June 30, 2020 | -0.4679M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.142M |
| December 31, 2019 | -0.3204M |
| September 30, 2019 | -0.1677M |
| June 30, 2019 | -0.2683M |
| March 31, 2019 | -0.078M |
| December 31, 2018 | 2.055M |
| September 30, 2018 | 7.582M |
| June 30, 2018 | 0.6231M |
| March 31, 2018 | 11.22M |
| December 31, 2017 | -0.6862M |
| September 30, 2017 | 0.8337M |
| June 30, 2017 | 3.130M |
| March 31, 2017 | 7.334M |
| December 31, 2016 | 1.931M |
| September 30, 2016 | -4.095M |
| June 30, 2016 | 5.795M |
| March 31, 2016 | 1.26M |
| December 31, 2015 | -27.59M |
| September 30, 2015 | 6.841M |
| June 30, 2015 | 4.846M |
| March 31, 2015 | -18.01M |
| December 31, 2014 | 6.659M |
| September 30, 2014 | 5.301M |
| June 30, 2014 | 1.970M |
| March 31, 2014 | -6.075M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Exelixis, Inc. | 91.43M |
| PTC Therapeutics, Inc. | -122.56M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.92M |
| Cash from Financing (Quarterly) | 0.0004M |
| Free Cash Flow | -78.18M |
| Free Cash Flow Per Share (Quarterly) | -0.736 |
| Free Cash Flow to Equity (Quarterly) | -19.87M |
| Free Cash Flow to Firm (Quarterly) | -20.92M |
| Free Cash Flow Yield | -16.95% |